Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
smallcase
More

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,098 cr, stock is ranked 1,164
High RiskStock is 3.75x as volatile as Nifty
419.350.00% (+0.00)
419.350.00% (+0.00)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,098 cr, stock is ranked 1,164
High RiskStock is 3.75x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,098 cr, stock is ranked 1,164
High RiskStock is 3.75x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
35.126.911.19%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
40.654.770.76%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jagsonpal Pharmaceuticals Limited is engaged in pharmaceutical business. It specializes in developing and manufacturing bulk drugs and pharmaceutical formulations.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.81%, vs industry avg of 8.45%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.06% to 0.08%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue138.26144.15157.14126.99168.26161.10192.34221.01242.44243.69
Raw Materialssubtract70.3365.3567.3465.1953.4354.9475.5083.3588.80200.66
Power & Fuel Costsubtract1.772.262.121.001.410.760.520.470.29
Employee Costsubtract32.1137.8440.9541.8846.6150.3753.9857.6865.18
Selling & Administrative Expensessubtract21.1726.5830.1927.5632.2341.0731.8842.5040.99
Operating & Other expensessubtract4.04-0.34-2.502.0123.812.906.998.5610.76
Depreciation/Amortizationsubtract2.713.091.990.321.021.131.091.531.211.40
Interest & Other Itemssubtract4.465.302.640.660.750.510.510.290.410.56
Taxes & Other Itemssubtract0.500.832.53-0.081.781.544.827.788.099.79
EPS0.451.244.53-4.412.763.016.517.2010.2011.94
DPS0.100.100.100.100.250.501.004.005.000.00
Payout ratio0.220.080.02—0.090.170.150.560.490.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF

Investor Presentation

Feb 22PDF
FY 2023

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jagsonpal Pharmaceuticals Ltd41.136.911.19%
Sun Pharmaceutical Industries Ltd32.814.690.99%
Cipla Ltd34.184.040.72%
Dr Reddy's Laboratories Ltd20.633.990.72%

Price Comparison

Compare JAGSNPHARM with any stock or ETF
Compare JAGSNPHARM with any stock or ETF
JAGSNPHARM
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding68.71%0.00%0.83%0.37%30.08%

Sep 2022

Dec 2022

Mar 2023

Jun 2023

Shareholding History

MarJunSepDec '22MarJun0.00%0.00%0.13%0.11%0.10%0.37%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Increasing Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

JAGSNPHARM has increased dividends consistently over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.20%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹12.01 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 21, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Aug 21, 2023

Cash Dividend

Ex DateEx DateOct 29, 2021

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

Oct 29, 2021

Cash Dividend

Ex DateEx DateSep 22, 2021

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 22, 2021

Cash Dividend

Ex DateEx DateSep 22, 2020

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 22, 2020

Cash Dividend

Ex DateEx DateSep 20, 2019

Final
Final | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Sep 20, 2019

News & Opinions

Hmm, looks like data is unavailable here. Please come back after some time.